Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in the People's Republic of China. More Details
Excellent balance sheet with limited growth.
Share Price & News
How has Ping An Healthcare and Technology's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1833 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 1833's weekly volatility (4%) has been stable over the past year.
7 Day Return
HK Healthcare Services
1 Year Return
HK Healthcare Services
Return vs Industry: 1833 underperformed the Hong Kong Healthcare Services industry which returned 7.6% over the past year.
Return vs Market: 1833 underperformed the Hong Kong Market which returned 21.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Ping An Healthcare and Technology's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StThe Ping An Healthcare and Technology (HKG:1833) Share Price Has Gained 61% And Shareholders Are Hoping For More
1 month ago | Simply Wall StWhat You Need To Know About Ping An Healthcare and Technology Company Limited's (HKG:1833) Investor Composition
2 months ago | Simply Wall StWe Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Is Ping An Healthcare and Technology undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: 1833 (HK$87.35) is trading above our estimate of fair value (HK$60)
Significantly Below Fair Value: 1833 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1833 is unprofitable, so we can't compare its PE Ratio to the Asian Healthcare Services industry average.
PE vs Market: 1833 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 1833's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 1833 is overvalued based on its PB Ratio (5.3x) compared to the XA Healthcare Services industry average (4.9x).
How is Ping An Healthcare and Technology forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1833 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 1833 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 1833 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 1833's revenue (21.2% per year) is forecast to grow faster than the Hong Kong market (12.8% per year).
High Growth Revenue: 1833's revenue (21.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1833 is forecast to be unprofitable in 3 years.
How has Ping An Healthcare and Technology performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1833 is currently unprofitable.
Growing Profit Margin: 1833 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 1833 is unprofitable, and losses have increased over the past 5 years at a rate of 4.4% per year.
Accelerating Growth: Unable to compare 1833's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1833 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (35.4%).
Return on Equity
High ROE: 1833 has a negative Return on Equity (-5.98%), as it is currently unprofitable.
How is Ping An Healthcare and Technology's financial position?
Financial Position Analysis
Short Term Liabilities: 1833's short term assets (CN¥15.3B) exceed its short term liabilities (CN¥2.7B).
Long Term Liabilities: 1833's short term assets (CN¥15.3B) exceed its long term liabilities (CN¥39.2M).
Debt to Equity History and Analysis
Debt Level: 1833 is debt free.
Reducing Debt: 1833 currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1833 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 1833 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Ping An Healthcare and Technology current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 1833's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1833's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 1833's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1833's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 1833's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Weihao Fang (47 yo)
Mr. Weihao Fang has been Chairman of the Board at Ping An Healthcare and Technology Company Limited since November 11, 2020 and has been its Executive Director and Chief Executive Officer since May 15, 202...
CEO Compensation Analysis
Compensation vs Market: Weihao's total compensation ($USD523.62K) is below average for companies of similar size in the Hong Kong market ($USD933.95K).
Compensation vs Earnings: Insufficient data to compare Weihao's compensation with company performance.
Experienced Management: 1833's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Experienced Board: 1833's board of directors are considered experienced (3.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.5%.
Ping An Healthcare and Technology Company Limited's company bio, employee growth, exchange listings and data sources
- Name: Ping An Healthcare and Technology Company Limited
- Ticker: 1833
- Exchange: SEHK
- Founded: 2014
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: HK$100.216b
- Shares outstanding: 1.15b
- Website: https://www.pagd.net
Number of Employees
- Ping An Healthcare and Technology Company Limited
- Shanghai Ping An Building
- 17-19 Floors
Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in the People's Republic of China. It offers online medical services, such...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/20 11:23|
|End of Day Share Price||2021/06/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.